Health News Archive - July 15, 2005
NEW YORK (Reuters Health) - The combination of the anti-cancer drugs Herceptin and Taxotere appears to work better than Taxotere alone in women with advanced breast cancer that has spread beyond the breast, research shows. Moreover, there is little added toxicity when Herceptin is given.
By Alison McCook NEW YORK (Reuters Health) - People who learned about relaxed breathing and received soothing touch and music before heart surgery were more likely to be alive 6 months after the procedure, suggesting that these additional steps help speed recovery, according to a study released today.
Many hangover sufferers looking for someone or something to blame can now point the finger at their own genes, according to a new study.
Everyone knows money can't buy happiness, and a new study suggests brains won't guarantee it, either. The study found that intelligence has both an upside and a downside.
Amid the debate over the value of prayer and so-called "noetic interventions" to help people heal, a new study finds that prayer and bedside therapy of music, imagery and touch don't improve the outcomes of patients undergoing heart procedures.
Even mild background noise in the home -- such as other children playing or watching television -- can impair a baby's ability to pick up language, researchers report.
WASHINGTON (Reuters) - U.S. regulators are investigating reports of deaths in patients who were using pain patches that contain the narcotic fentanyl, the Food and Drug Administration said on Friday.
WASHINGTON (Reuters) - U.S. regulators are investigating reports of deaths of patients who were using pain patches that contain the narcotic fentanyl, the Food and Drug Administration said on Friday. Johnson & Johnson sells fentanyl patches under the brand name Duragesic, and Mylan Laboratories Inc.
By Anthony J. Brown, MD NEW YORK (Reuters Health) - New research suggests that gene variants, which are known to raise the risk of asthma, decrease the risk of glioblastoma multiforme (GBM), a common type of brain cancer that is rapidly fatal.
By David Douglas NEW YORK (Reuters Health) - In a Mediterranean population typically at low risk for developing melanoma, carriers of mutations in the pigmentation gene MC1R are at increased risk of developing the skin cancer and having it progress, a study hints.